RafaelAntionioMunne Md PaMD

Journal Articles

• Possible predictors of neuroleptic resistant schizophrenic relapse: Influence of negative symptoms and acute extrapyramidal side effects  
  Kinon J, Kane JM, Chakos M, Munne R, Psychopharmacol Bull, 1/1/1993
• The dopamine serotonin relationship in Clozapine response  
  Szymanski S, Lieberman J, Pollack S, Munne R, Safferman A, Kane J, Kronig M, Cooper T, Psychopharmacology, 1/1/1993
• A selective review of recent advances in the management of Tardive Dyskinesia  
  Szymanski S, Munne R, Gordon MF, Lieberman J, Psychiatric Annals, 1/1/1993
• Combining Clozapine with ECT  
  Safferman AZ, Munne RA, Convulsive Therapy, 1/1/1992
• Join now to see all

Abstracts/Posters

• Three-dimensional magnetic resonance brain image reformatting to a standardized coordinate system
  H, Munne R, Bilder R, Lerner G, Redmond M, Lieberman J, American Psychiatric Association Annual Meeting, Philadelphia, PA, 1/1/1994
• Increased inter putamen distance brain width ratio in first episode and chronic schizophrenic patients
  Wu H, Munne R, Bilder R, Bogerts B, Lieberman J, American Psychiatric Association Annual Meeting, Philadelphia, PA, 1/1/1994
• Behavioral effect of m chlorophenylpiperazine (MCPP) and methylphenidate in first episode schizophrenia and normal controls
  Koreen AR, Lieberman J, Szymanski S, Chakos M, Alvir J, Munne R, American Psychiatric Association Annual Meeting, Philadelphia, PA, 1/1/1994
• Plasma Clozapine levels and treatment response in treatment refractory schizophrenics
  Munne RA, Szymanski SR, Safferman AZ, Pollack S, Cooper T, Lieberman J, 145th Annual Conference, American Psychiatric Association, Washington, DC, 1/1/1992
• Gender effects in neuroleptic nonresponsive schizophrenics treated with Clozapine
  Szymanski S, Lieberman J, Pollack S, Woerner M, Munne R, Kane J, Masiar S, Galkowski B, Safferman A, 145th Annual Conference of the American Psychiatric Association, Washington, DC, 1/1/1992
• Gender differences in the presentation, course and out come of first episode schizophrenics
  Szymanski S, Lieberman J, Alvir JMa, Woerner M, Geisler S, Lobel A, Mayerhoff D, Munne R, 145th Annual Conference of the American Psychiatric Association, Washington, DC, 1/1/1992
• Pharmacologic indices of gender effects in first episode schizophrenics
  Szymanski S, Lieberman J, Alvir JMa, Woerner, M, Geisler S, Lobel A, Chakos M, Koreen A, Munne R, 145th Annual Conference of the American Psychiatric Association, Washington, DC, 1/1/1992
• Gender differences in the presentation: Course and outcome of first episode schizophrenics
  Szymanski S, Lieberman J, Alvir, JMa, Woerner M, Geisler S, Loebel A, Mayerhoff DI, Munne, R, The Society for Biological Psychiatry Annual Meeting, Washington, DC, 1/1/1992
• The behavioral effects of IV MCPP in schizophrenia
  Szymanski S, Mayerhoff D, Lieberman J, Alvir JMa, Munne R, Koreen A, Loebel A, Geisler S, Chakos M, The Society for Biological Psychiatry Annual Meeting, Washington, DC, 1/1/1992
• Gender in neuroleptic nonresponsive schizophrenics treated with Clozapine
  Szymanski S, Lieberman J, Pollack S, Woerner M, Munne R, Galkowski B, Masiar S, Safferman A, The Society for Biological Psychiatry Meeting, Washington, DC, 1/1/1992
• Join now to see all